Effect of perhexiline and oxfenicine on myocardial function and metabolism during low-flow ischemia/reperfusion in the isolated rat heart

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 6, 2000, Pages 794-801

  Kennedy, J A ^a   Kiosoglous, A J ^a   Murphy, G A ^a   Pelle, M A ^a   Horowitz, J D ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cardiac; Carnitine palmitoyltransferase; Ischemia reperfusion; Oxfenicine; Perhexiline; Rat

Indexed keywords

ACYLCARNITINE; CARNITINE PALMITOYLTRANSFERASE; LACTIC ACID; MALONYL COENZYME A; OXFENICINE; PERHEXILINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME INHIBITION; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART MUSCLE TENSION; HEART PROTECTION; HEMODYNAMICS; IC 50; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033653158     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200012000-00016     Document Type: Article

References (35)

1. Regulation of fatty acid oxidation in the mammalian heart in health and disease
2. Effects of palmitoylcarnitine and LPC on sarcolemmal Na+K+ATPase
3. Aliphatic chain saturation and polar region influence amphiphile effects on sarcoplasmic reticulum calcium sequestration
4. On the roles of long-chain acylcarnitine accumulation and impaired glucose utilization in ischaemic contracture development and tissue damage in the guinea-pig heart
5. Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischaemic rat heart
6. Oleate plus oxfenicine improves functional recovery, assessed via an intraventricular balloon, in ischemic-reperfused rat hearts
7. Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase 1 inhibition during reduction in coronary flow in acutely and chronically diabetic rats
8. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis
9. Efficacy and safety of perhexiline maleate in refractory angina
10. Alteration of left ventricular responses to ischemia with oral perhexiline
11. Effects of perhexiline on coronary hemodynamic and myocardial metabolic responses to tachycardia
12. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart
13. Direct evidence that perhexiline modifies myocardial substrate utilization from fatty acid to glycolytic sources
14. Inhibition of carnitine palmitoytransferase-1 in rat heart and liver by perhexiline and amiodarone
15. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase-1 in animal and human tissues
16. Carnitine palmitoyltransferase 1. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA
17. Colorimetric measurement of plasma lactate
18. Rapid method for the separation and detection of tissue short-chain coenzyme A esters by reversed-phase high-performance liquid chromatography
19. Isolation of liver or kidney mitochondria
20. Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system II use of detergents and antibodies
21. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction
22. Alterations in isoproterenol-induced cardiac metabolic changes by perhexiline
23. Effects of the fatty acid blocking agents, oxfenicine and 4-bromocrotonic acid, on performance in aerobic and ischemic myocardium
24. Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine
25. Cellular uncoupling induced by accumulation of long-chain acylcarnitine during ischemia
26. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia
27. Metabolic oxidation of glucose during early myocardial reperfusion
28. Mechanisms of substrate preference for oxidative metabolism during early myocardial reperfusion
29. Inhibition of long-chain acylcarnitine accumulation during coronary artery occlusion does not alter infarct size in dogs
30. Reperfusion-induced accumulation of long-chain acylcarnitines in previously ischemic myocardium
31. Perhexiline maleate treatment for severe angina pectoris - Correlations with pharmacokinetics
32. Comparisons of negative inotropic potency, reversibility, and effects of calcium influx of six calcium channel antagonists in cultured myocardial cells
33. Excretion, blood levels and tissue retention of perhexiline-14C maleate in dogs
34. Inhibition by perhexiline of oxidative phosphorylation and the β-oxidation of fatty acids: Possible role in pseudoalcoholic liver lesions